SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (6853)4/12/1998 10:56:00 PM
From: incomep  Read Replies (1) of 23519
 
BigKNY3 << Still not sure who you think is the rat.>>
Longtime ago, the big guys created a hype while they are selling and shorting at the rally, the rapid drop left our poor small longs holding the bag. This time, I hope it is not the opposite that they create this demise mood (posts of happy Viagra users without side effects, a long list of lawsuits against VVUS, impotent mgmt, rapidly erosion of muse sale after the V-pill), <<My conclusion FROM THAT TREAD and lawsuits and the nay sayers are that muse is not worth anything, so is this one product company. Therefore, keep short it to zero.>> and we should continue shorting it with any up-sticks even it is a single digit from high $42. Do I see they are covering while the small guys are shorting? I think so.

<<The usual dosage rate is 50 mg which has a 65%-80% efficacy rate>>
JFD ,no, note they all failed at the lower doses. Ed
#6105, Mar 23 1998 9:05PM

Zebra 365 Our small # of patients (6) on viagra did poorly on all doses belo
#6100, Mar 23 1998 6:02PM by Ed

Do I believe these happy posters and the "cheer leaders", or believe Edderd, our long poster who never swayed like our lovely traders (docs, pros, and the gloss-over-ers). I am afraid that the long track of Edderd demonstrated this old urologist's integrity and expertise of ED, plus, "a very, very long term shareholder of VVUS" (check his profile and all the past posts)

<<I am not sure what you are trying to say.>>
Muse sale is more than twice the injection. However, no one there mentioned a single successful case with muse. My conclusion FROM THAT TREAD and lawsuits and the nay sayers are that muse is not worth anything, so is this one product company. Therefore, keep short it to zero. Did not you mention months ago on this thread that you never short stocks, and you are a pro-knowledge. Ha, I guess, muse helps you grow on many ways.

Short or long a stock can blind a person. (are not you a long, long Pfe holders)

<<Headaches are the #1 adverse reaction for Viagra (16% of all patients)>>
No wondering that the 5 happy pill users on your post (alt.support. impotant) have no side effect. I bet the No 7th will have (7x16% >100%) the 7 hours headache like Mr. diceguy.

<<Before you invest in VVUS on Monday, I suggest thinking about the following>>
Re-read the annual report with whole morning, I see the fundamentals of the company are building up rapidly. Phase III clinical trial of muse II. Finished new plant waiting for FDA approval in this quart. The approval of South Korea and other pacific countries and Europe. Application of approval for the most populated country, China, and the neighbor countries, Canada and Mexico. Geared-up sales forces.
Should I keep long (if I am long) and cover my short (if I am short) or keep shorting with any up-sticks, you can judge.

Still a nice call for Pfe $100.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext